Elmwood Park, March 16 -- Glenmark Pharmaceuticals Inc USA has announced the upcoming launch of 'Potassium Phosphates Injection USP', 15 mmol P / 22 mEq K per 5 mL and 45 mmol P / 66 mEq K per 15 mL single-dose vials and 150 mmol P / 220 mEq K per 50 mL Pharmacy Bulk Package Vials.
According to a statement released by the pharmaceutical company, "Glenmark's Potassium Phosphates Injection USP, 15 mmol P / 22 mEq K per 5 mL and 45 mmol P / 66 mEq K per 15 mL Single-Dose Vials and 150 mmol P / 220 mEq K per 50 mL Pharmacy Bulk Package Vials is bioequivalent and therapeutically equivalent to the reference listed drug, Potassium Phosphates Injection USP, 15 mmol P / 22 mEq K per 5 mL, 45 mmol P / 66 mEq K per 15 mL, and 150 mmol P / 220 mEq K...
Click here to read full article from source
To read the full article or to get the complete feed from this publication, please
Contact Us.
